Radient Pharmaceuticals Corporation fka RXPC

[invest4future]

Hi DOC, following is the post I mentioned recently. Would you mind input or comment? Thanks.

Have following the discussion between you and Gold as well as between Vestor_guy and Mfcav01 (on yahoo mesg brd) for a while. These discussions did help to buildup some basic science and commonsense. The good side of Onko Sure is the early detection, easy application (risk free) and low cost, all depends on how we will administer the test to minimize the downside of false detection.

May you cast some light on the following questions?

1. By which means doctors detected the colon cancer in the early stage (stage I and II) currently?
Roughtly what's the percentage of the patients who were detected in stage I and II by means other than blood test?

2. When a person has elevated FDP level in a test with onko-sure, while he is free of cancer,
would this level maintain the higher than normal level in subsequent tests? (eg. one or two test monthly after the first)?

And when a person has cancer in progression in the early stage, would the FDP level increase with time?

And for your comments about the lung cancer detection, I found a link about a completed study between RPC and Provista and the ongoing test kit named Sentinel. IMO, this will benefit a lot for smokers (active or passive) and people in specific occupations with higher risk of lung cancer. My understanding that lung cancer is a big issues in the developing countries such as China and India, where a very big/huge population of smoking, onko-sure can play a role for the early detection and save many lives.

http://www.provistals.com/AboutLungCancerTest.aspx
Provista and RPC has an acquisition intent that is on hold currently.